Patents by Inventor Lars Sandberg
Lars Sandberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190155747Abstract: There is provided an apparatus that includes an input port to receive, from a requester, any one of: a lookup operation comprising an input address, and a maintenance operation. Maintenance queue circuitry stores a maintenance queue of at least one maintenance operation and address storage stores a translation between the input address and an output address in an output address space. In response to receiving the input address, the output address is provided in dependence on the maintenance queue. In response to storing the maintenance operation, the maintenance queue circuitry causes an acknowledgement to be sent to the requester. By providing a separate maintenance queue for performing the maintenance operation, there is no need for a requester to be blocked while maintenance is performed.Type: ApplicationFiled: October 24, 2018Publication date: May 23, 2019Inventors: Andreas Lars SANDBERG, Nikos NIKOLERIS, Prakash S. RAMRAKHYANI, Stephan DIESTELHORST
-
Patent number: 10231967Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.Type: GrantFiled: January 31, 2018Date of Patent: March 19, 2019Assignee: AstraZeneca ABInventors: Gabor Csjernyik, Sofia Karlstrom, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg, Laszlo Rakos, Lars Sandberg, Fernando Sehgelmeble, Peter Soderman, Britt-Marie Swahn, Stefan Von Berg
-
Publication number: 20190004960Abstract: An apparatus and method are provided for handling caching of persistent data. The apparatus comprises cache storage having a plurality of entries to cache data items associated with memory address in a non-volatile memory. The data items may comprise persistent data items and non-persistent data items. Write back control circuitry is used to control write back of the data items from the cache storage to the non-volatile memory. In addition, cache usage determination circuitry is used to determine, in dependence on information indicative of capacity of a backup energy source, a subset of the plurality of entries to be used to store persistent data items. In response to an event causing the backup energy source to be used, the write back control circuitry is then arranged to initiate write back to the non-volatile memory of the persistent data items cached in the subset of the plurality of entries.Type: ApplicationFiled: June 12, 2018Publication date: January 3, 2019Inventors: Wei Wang, Stephan Diestelhorst, Wendy Arnott ELSASSER, Andreas Lars Sandberg, Nikos NIKOLERIS
-
Publication number: 20180365142Abstract: Broadly speaking, embodiments of the present technique provide an apparatus and methods for improved wear-levelling in non-volatile memory (NVM) devices. In particular, the present wear-levelling techniques operate on small blocks within a memory device, at a finer scale/granularity than that used by common wear-levelling techniques which often remap large blocks (e.g. several kilobytes) of data.Type: ApplicationFiled: December 2, 2016Publication date: December 20, 2018Applicant: Arm LimitedInventors: Andreas Lars SANDBERG, Irenéus Johannes de JONG, Andreas Hansson
-
Publication number: 20180232313Abstract: A system cache and method of operating a system cache are provided. The system cache provides data caching in response to data access requests from plural system components. The system cache has data caching storage with plural entries, each entry storing a block of data items and each block of data items comprising plural sectors of data items, and each block of data items being stored in an entry of the data caching storage with an associated address portion. Sector use prediction circuitry is provided which has a set of pattern entries to store a set of sector use patterns. In response to a data access request received from a system component specifying one or more data items a selected pattern entry is selected in dependence on a system component identifier in the data access request and a sector use prediction is generated in dependence on a sector use pattern in the selected pattern entry.Type: ApplicationFiled: January 29, 2018Publication date: August 16, 2018Inventors: Nikos NIKOLERIS, Andreas Lars SANDBERG, Jonas SVEDAS, Stephan DIESTELHORST
-
Publication number: 20180221367Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.Type: ApplicationFiled: January 31, 2018Publication date: August 9, 2018Inventors: Gabor Csjernyik, Sofia KARLSTRÖM, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg, Laszlo Rakos, Lars Sandberg, Fernando Sehgelmeble, Peter Soderman, Britt-Marie Swahn, Stefan Von Berg
-
Publication number: 20180203802Abstract: A cache apparatus is provided comprising a data storage structure providing N cache ways that each store data as a plurality of cache blocks. The data storage structure is organised as a plurality of sets, where each set comprises a cache block from each way, and further the data storage structure comprises a first data array and a second data array, where at least the second data array is set associative. A set associative tag storage structure stores a tag value for each cache block, with that set associative tag storage structure being shared by the first and second data arrays. Control circuitry applies an access likelihood policy to determine, for each set, a subset of the cache blocks of that set to be stored within the first data array.Type: ApplicationFiled: January 8, 2018Publication date: July 19, 2018Inventors: Ricardo Daniel Queiros ALVES, Nikos NIKOLERIS, Shidhartha DAS, Andreas Lars SANDBERG
-
Publication number: 20180157437Abstract: An apparatus and method are provided for transferring data between address ranges in memory. The apparatus comprises a data transfer controller, that is responsive to a data transfer request received by the apparatus from a processing element, to perform a transfer operation to transfer data from at least one source address range in memory to at least one destination address range in the memory. A redirect controller is then arranged, whilst the transfer operation is being performed, to intercept an access request that specifies a target address within a target address range, and to perform a memory redirection operation so as to cause the access request to be processed without awaiting completion of the transfer operation.Type: ApplicationFiled: November 8, 2017Publication date: June 7, 2018Inventors: Andreas Lars SANDBERG, Nikos NIKOLERIS, David Hennah MANSELL
-
Patent number: 9918985Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.Type: GrantFiled: July 26, 2017Date of Patent: March 20, 2018Assignee: ASTRAZENECA ABInventors: Gabor Csjernyik, Sofia Karlstrom, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg, Laszlo Rakos, Lars Sandberg, Fernando Sehgelmeble, Peter Soderman, Britt-Marie Swahn, Stefan Von Berg
-
Publication number: 20170319578Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.Type: ApplicationFiled: July 26, 2017Publication date: November 9, 2017Inventors: Gabor Csjernyik, Sofia Karlstrom, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg, Laszlo Rakos, Lars Sandberg, Fernando Sehgelmeble, Peter Soderman, Britt-Marie Swahn, Stefan Von Berg
-
Publication number: 20160184303Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.Type: ApplicationFiled: December 22, 2015Publication date: June 30, 2016Inventors: Gabor Csjernyik, Sofia Karlstrom, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg, Laszlo Rakos, Lars Sandberg, Fernando Sehgelmeble, Peter Soderman, Britt-Marie Swahn, Stefan Von Berg
-
Patent number: 9248129Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.Type: GrantFiled: September 15, 2014Date of Patent: February 2, 2016Assignee: ASTRAZENECA ABInventors: Gabor Csjernyik, Sofia Karlstrom, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg, Laszlo Rakos, Lars Sandberg, Fernando Sehgelmeble, Peter Soderman, Britt-Marie Swahn, Stefan Von Berg
-
Publication number: 20150133471Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.Type: ApplicationFiled: September 15, 2014Publication date: May 14, 2015Inventors: Gabor Csjernyik, Sofia Karlstrom, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg, Laszlo Rakos, Lars Sandberg, Fernando Sehgelmeble, Peter Soderman, Britt-Marie Swahn, Stefan Von Berg
-
Patent number: 9000183Abstract: Cyclohexane-1,2?-indene-1?,2?-imidazole compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration, methods of therapy using such compounds, and pharmaceutical compositions containing such compounds.Type: GrantFiled: June 13, 2013Date of Patent: April 7, 2015Assignee: Astrazeneca ABInventors: Sofia Karlstrom, Peter Soderman, Laszlo Rakos, Liselotte Ohberg, Karin Kolmodin, Lars Sandberg
-
Patent number: 9000182Abstract: 2H-imidazol-4-amine compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. methods of therapy, and pharmaceutical compositions containing such compounds.Type: GrantFiled: June 13, 2013Date of Patent: April 7, 2015Assignee: AstraZeneca ABInventors: Sofia Karlstrom, Gabor Csjernyik, Britt-Marie Swahn, Lars Sandberg, Karin Kolmodin, Peter Soderman, Liselotte Ohberg
-
Patent number: 9000184Abstract: Cyclohexane-1,2?-naphthalene-1?,2?-imidazole compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration, methods of therapy using such compounds, and pharmaceutical compositions containing such compounds.Type: GrantFiled: June 13, 2013Date of Patent: April 7, 2015Assignee: AstraZeneca ABInventors: Sofia Karlstrom, Lars Sandberg, Peter Soderman, Karin Kolmodin, Liselotte Ohberg
-
Patent number: 8865911Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.Type: GrantFiled: March 15, 2013Date of Patent: October 21, 2014Assignee: Astrazeneca ABInventors: Gabor Csjernyik, Sofia Karlstrom, Annika Kers, Karin Kolmodin, Martin Nylof, Liselotte Ohberg, Laszlo Rakos, Lars Sandberg, Fernando Sehgelmeble, Peter Soderman, Britt-Marie Swahn, Stefan Von Berg
-
Publication number: 20130345247Abstract: Cyclohexane-1,2?-indene-1?,2?-imidazole compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration, methods of therapy using such compounds, and pharmaceutical compositions containing such compounds.Type: ApplicationFiled: June 13, 2013Publication date: December 26, 2013Applicant: ASTRAZENECA ABInventors: Sofia Karlstrom, Peter Soderman, Laszlo Rakos, Liselotte Ohberg, Karin Kolmodin, Lars Sandberg
-
Publication number: 20130345248Abstract: Cyclohexane-1,2?-naphthalene-1?,2?-imidazole compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration, methods of therapy using such compounds, and pharmaceutical compositions containing such compounds.Type: ApplicationFiled: June 13, 2013Publication date: December 26, 2013Applicant: AstraZeneca ABInventors: Sofia Karlstrom, Lars Sandberg, Peter Soderman, Karin Kolmodin, Liselotte Ohberg
-
Publication number: 20130345246Abstract: 2H-imidazol-4-amine compounds, therapeutically acceptable salts thereof, processes for preparation thereof, therapeutic uses of such compounds for treating A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy, Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. methods of therapy, and pharmaceutical compositions containing such compounds.Type: ApplicationFiled: June 13, 2013Publication date: December 26, 2013Applicant: ASTRAZENECA ABInventors: Sofia Karlstrom, Gabor Csjernyik, Britt-Marie Swahn, Lars Sandberg, Karin Kolmodin, Peter Soderman, Liselotte Ohberg